SciVision Biotech Inc. (TPE:1786)
52.60
+0.40 (0.77%)
May 29, 2026, 1:30 PM CST
SciVision Biotech Market Cap
SciVision Biotech has a market cap or net worth of 3.94 billion as of May 29, 2026. Its market cap has decreased by -43.18% in one year.
Market Cap
3.94B
Enterprise Value
3.33B
Revenue
887.61M
Ranking
n/a
PE Ratio
30.89
Stock Price
52.60
Market Cap Chart
Since December 29, 2010, SciVision Biotech's market cap has increased from 1.23B to 3.94B, an increase of 220.39%. That is a compound annual growth rate of 7.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 3.94B | -24.90% |
| Dec 31, 2025 | 5.24B | -29.80% |
| Dec 31, 2024 | 7.47B | 42.10% |
| Dec 29, 2023 | 5.25B | 46.46% |
| Dec 30, 2022 | 3.59B | 9.27% |
| Dec 30, 2021 | 3.28B | -12.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medeon Biodesign | 8.49B |
| Bioteque | 7.87B |
| Pacific Hospital Supply | 5.74B |
| Formosa Optical Technology | 5.63B |
| St.Shine Optical | 4.67B |
| Bionime | 4.04B |
| ICARES Medicus | 3.44B |
| Maxigen Biotech | 3.44B |